Rejuvenate Bio secures funding and Merck partnership

New funds and strategic collaboration with Merck Animal Health will support development of therapies targeting age-related diseases in pets. Rejuvenate Bio has closed a $6 million financing round and entered a strategic R&D collaboration with Merck Animal Health – a pairing that brings one of the world’s largest animal health companies into direct contact with […] The post Rejuvenate Bio secures funding and Merck partnership appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.